Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > weekend update & week ahead

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Aug 20, 2024 2:58pm

75 Views

Post# 36188469

RE:RE:weekend update & week ahead

Haha what a childish little buffoon. Every call yoube made on here is in the dirt.

I asked you before you before to share your wisdom. What should we buy, for how much and when do we sell. You keep avoiding the opportunity to prove yourself.

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting